These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28806794)

  • 1. Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder: A Systematic Review.
    O'Neil ME; Nugent SM; Morasco BJ; Freeman M; Low A; Kondo K; Zakher B; Elven C; Motu'apuaka M; Paynter R; Kansagara D
    Ann Intern Med; 2017 Sep; 167(5):332-340. PubMed ID: 28806794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review.
    Nugent SM; Morasco BJ; O'Neil ME; Freeman M; Low A; Kondo K; Elven C; Zakher B; Motu'apuaka M; Paynter R; Kansagara D
    Ann Intern Med; 2017 Sep; 167(5):319-331. PubMed ID: 28806817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review of the Clinical Effects of Cannabis and Cannabinoids in Posttraumatic Stress Disorder Symptoms and Symptom Clusters.
    Rodas JD; George TP; Hassan AN
    J Clin Psychiatry; 2024 Feb; 85(1):. PubMed ID: 38353645
    [No Abstract]   [Full Text] [Related]  

  • 4. Cannabis and Complex Posttraumatic Stress Disorder: A Narrative Review With Considerations of Benefits and Harms.
    Dagan Y; Yager J
    J Nerv Ment Dis; 2020 Aug; 208(8):619-627. PubMed ID: 32433200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
    Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Long-Term, Prospective, Therapeutic Impact of Cannabis on Post-Traumatic Stress Disorder.
    Bonn-Miller MO; Brunstetter M; Simonian A; Loflin MJ; Vandrey R; Babson KA; Wortzel H
    Cannabis Cannabinoid Res; 2022 Apr; 7(2):214-223. PubMed ID: 33998874
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study.
    De Aquino JP; Sofuoglu M; Stefanovics EA; Rosenheck RA
    Am J Drug Alcohol Abuse; 2020 Nov; 46(6):812-822. PubMed ID: 33035104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program.
    Greer GR; Grob CS; Halberstadt AL
    J Psychoactive Drugs; 2014; 46(1):73-7. PubMed ID: 24830188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review.
    Hindocha C; Cousijn J; Rall M; Bloomfield MAP
    J Dual Diagn; 2020; 16(1):120-139. PubMed ID: 31479625
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits and harms of medical cannabis: a scoping review of systematic reviews.
    Pratt M; Stevens A; Thuku M; Butler C; Skidmore B; Wieland LS; Clemons M; Kanji S; Hutton B
    Syst Rev; 2019 Dec; 8(1):320. PubMed ID: 31823819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review.
    Steenkamp MM; Blessing EM; Galatzer-Levy IR; Hollahan LC; Anderson WT
    Depress Anxiety; 2017 Mar; 34(3):207-216. PubMed ID: 28245077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders.
    Cohen J; Wei Z; Phang J; Laprairie RB; Zhang Y
    J Clin Neurophysiol; 2020 Jan; 37(1):28-34. PubMed ID: 31895187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review.
    Kondo KK; Morasco BJ; Nugent SM; Ayers CK; O'Neil ME; Freeman M; Kansagara D
    Ann Intern Med; 2020 Mar; 172(6):398-412. PubMed ID: 32120384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive posttraumatic stress disorder screens among first-time medical cannabis patients: prevalence and association with other substance use.
    Bohnert KM; Perron BE; Ashrafioun L; Kleinberg F; Jannausch M; Ilgen MA
    Addict Behav; 2014 Oct; 39(10):1414-7. PubMed ID: 24930048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician's perspective.
    Ney LJ; Akosile W; Davey C; Pitcher L; Felmingham KL; Mayo LM; Hill MN; Strodl E
    Expert Rev Clin Pharmacol; 2023; 16(11):1093-1108. PubMed ID: 37885234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion.
    Krediet E; Janssen DG; Heerdink ER; Egberts TC; Vermetten E
    Eur Neuropsychopharmacol; 2020 Jul; 36():244-254. PubMed ID: 32576481
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.